BFBajaj Finserv MFRegular · Growth

Bajaj Finserv Healthcare Fund - Regular Plan - Growth

Pharma & Health CareEquity - Sectoral Fund - Pharma & Health CareBenchmark: BSE Health Care - TRI
NAV · 15 Sep 2026₹11.74-1.49%
AUM₹406 Cr
Expense Ratio2.59%
1Y CAGR+18.49%
Exit Load1% on or before 3M, Nil after 3M
Min SIP₹1,000
Launched2024

Investment Objective

The objective of the Scheme is to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies.

Fund Mandate

Equities and Equity related securities of other than pharma, healthcare and allied companies0%–20%
Equity and Equity Related Securities of pharma, healthcare and allied companies80%–100%
MMI other liquid instruments, Units of InvITs, Units of Gold ETFs and Silver ETFs and units of Liquid, Overnight and Money Market MF0%–20%
Units issued by REITs and InvITs 0%–10%
Asset Allocation
Domestic Equity96.0%
Cash & Equivalents2.7%
Other1.3%
Fund Managers
VB
Vinay Bafna
Fund Manager
Key Information
2.59%
₹1,000
₹500
1% on or before 3M, Nil after 3M
Nil
Inception27 Dec 2024
AMCBajaj Finserv MF
Top Holdings
1Divi's Laboratories LimitedPharmaceuticals & Biotechnology10.55%
2Sun Pharmaceutical Industries LimitedPharmaceuticals & Biotechnology8.21%
3Rubicon Research LimitedPharmaceuticals & Biotechnology6.81%
4Piramal Pharma LimitedPharmaceuticals & Biotechnology6.72%
5Aurobindo Pharma LimitedPharmaceuticals & Biotechnology6.18%
6Apollo Hospitals Enterprise LimitedHealthcare Services6.00%
7Torrent Pharmaceuticals LimitedPharmaceuticals & Biotechnology5.03%
8Neuland Laboratories LimitedPharmaceuticals & Biotechnology4.11%
9Emcure Pharmaceuticals LimitedPharmaceuticals & Biotechnology3.84%
10Max Healthcare Institute LimitedHealthcare Services3.35%
Sector Allocation
Pharmaceuticals & Biotechnology62.8%
Healthcare Services14.3%
Food Products2.3%
Other2.1%
Consumer Durables2.0%
Trailing Returns
PeriodReturnsCategory avg
1 Day-1.49%
1 Week-2.81%-2.62%
1 Month+0.75%-4.01%
3 Months+12.02%+0.58%
6 Months+27.71%+9.14%
9 Months+21.21%+1.98%
1 Year+18.49%+1.64%
+9.78%+16.23%

Category avg is the average return of every scheme in this fund's SEBI class (Equity - Sectoral Fund - Pharma & Health Care) over the same period. Returns up to 1 year are absolute; returns beyond 1 year are annualised (CAGR). This is Accord's own stated convention for equity-oriented schemes.

Risk Metrics
13.83%

A measure of how much a fund's returns swing up and down over time. Higher means a bumpier ride — more volatility — even if the average return ends up the same as a steadier fund.

0.70

How sensitive a fund is to overall market moves. A beta of 1 means it roughly moves in line with the market; below 1 means smaller swings than the market; above 1 means bigger swings in both directions.

-0.38

How much extra return a fund earned for every unit of risk (volatility) it took on, compared to a safe, risk-free investment. Higher means better risk-adjusted performance — not just higher returns, but smarter ones.

-3.85%

The extra return a fund generated above what its benchmark index would predict, given the risk it took. Positive alpha suggests the fund manager added genuine value beyond just tracking the market.

-0.64

Similar to the Sharpe Ratio, but only counts downside volatility (the bad kind) rather than penalizing a fund for volatile-but-positive swings. Higher means better returns per unit of "harmful" risk.

-9.41%

The single worst peak-to-trough fall a fund has experienced over a given period — the deepest "how much would I have lost if I'd bought at the top and sold at the bottom" scenario.

Fees
2.59%
1% on or before 3M, Nil after 3M
Nil
₹1,000
₹500
Capital Gains Tax, general rules

This is an equity-oriented fund. Under rules effective since Budget 2024 (23 July 2024):

Short-Term Capital Gains (held ≤ 12 months): taxed at a flat 20%.

Long-Term Capital Gains (held > 12 months): taxed at 12.5% on gains above ₹1.25 lakh in a financial year, with no indexation benefit.

General information only, not tax advice, actual liability depends on your overall income and applicable law at the time of redemption. Consult a tax advisor for your specific situation.

Frequently Asked QuestionsGeneral mutual-fund FAQs, not specific to this scheme